Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I

基于网络的社交互动可延缓 MCI 老年人认知能力下降:第一阶段

基本信息

  • 批准号:
    9930344
  • 负责人:
  • 金额:
    $ 40.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

Larger social networks and/or more frequent social interactions are associated with lower incidence of AD, at the population level; increasing social interaction may be a promising intervention for improving the cognitive well-being of older adults. In our previous randomized controlled behavioral clinical trial, we developed a conversation-based social interaction cognitive stimulation protocol delivered by trained interviewers through personal computers, webcams, and a user-friendly interactive Internet interface with a touch screen (ClinicalTrials.gov:NCT01571427). Daily 30-minute face-to-face communications were conducted over a 6- week trial period in the intervention group. Despite a small sample size, this pilot study (completed 6/30/2014) demonstrated feasibility, high adherence in an elderly population (mean age 80 years) and efficacy in language-based executive functions among the intervention group in comparison to the control group. Based upon these positive results, we propose a Phase I trial to advance development of this intervention. Primary aim (Aim 1) is to examine the efficacy of our intervention on cognitive functions among the target group - those aged 80 and older with MCI and limited opportunities of social interactions. Our primary outcomes are cognitive functions in the domains of language, attention, executive and memory functions, and secondary outcomes are a targeted IADL function (medication use and adherence) and overall emotional well-being (mood, self-rated health). Person-specific levels of social interactions (i.e., average conversation outside of the trial) will be monitored and controlled in the analyses. Exploratory Aim 2 is to examine whether the intervention could lead to changes in speech and language characteristics over time by analyzing recorded daily conversational sessions, based on our promising cross-sectional findings in this area. Exploratory Aim 3 is to examine underlying mechanisms of efficacy by assessing pre- and post- trial changes inhippocampal, dorsolateral prefrontal cortex, amygdala and other ROIsusing MRI and unbiased whole brain assessment (voxel-based morphometry), and structural and functional connectivity using diffusion tensor imaging (DTI) and resting state functional MRI (R-fMRI). A total of 144 MCI subjects will be recruited and randomized at Portland, Oregon, and Detroit, Michigan, collaborating with Meals on Wheels and Area Agency on Aging (AAA) at both locations, creating a large sampling frame of those with low income and from ethnic minorities. Half of the participants will be randomly selected and invited to participate in the brain imaging study. Increasing daily social contact through communication technologies could offer a cost-effective home- based prevention that could slow cognitive decline, delay the onset of AD, and thereby reduce the overall societal burden of dementia. The oldest old is the fastest growing segment of the population in most developed countries, and face the highest risk of developing dementia and social isolation (risk factors of adverse health outcomes). User-friendly sustainable prevention approaches are urgently needed in this population.
更大的社交网络和/或更频繁的社交互动与AD的发病率较低相关, 人口水平;增加社会互动可能是改善认知能力的有希望的干预措施。 老年人的福祉。在我们之前的随机对照行为临床试验中,我们开发了一种 基于对话的社交互动认知刺激协议,由经过培训的面试官通过 个人电脑、网络摄像头和带有触摸屏的用户友好交互式互联网界面 (ClinicalTrials.gov:NCT 01571427)。每天进行30分钟的面对面交流, 干预组试用期为1周。尽管样本量较小,但该初步研究(2014年6月30日完成) 在老年人群(平均年龄80岁)中证明了可行性、高依从性和 与对照组相比,干预组的语言执行功能。 基于这些积极的结果,我们提出了一个I期试验,以推进这一发展。 干预主要目的(目的1)是检查我们的干预对认知功能的有效性, 目标群体-80岁及以上的MCI患者和社交机会有限的人。我们 主要结果是语言、注意力、执行力和记忆领域的认知功能 功能,次要结局是目标IADL功能(药物使用和依从性)和总体 情绪健康(情绪,自我评价的健康)。个人特定的社会互动水平(即,平均 试验外的谈话)将在分析中进行监测和控制。探索目标2是 检查干预是否会导致言语和语言特征随时间的变化, 根据我们在这一领域有希望的横截面发现,分析记录的日常会话。 探索性目的3是通过评估试验前后的变化来检查疗效的潜在机制 额叶皮层、背外侧前额叶皮层、杏仁核和其他ROI使用MRI和无偏全脑 评估(基于体素的形态测量),以及使用扩散张量的结构和功能连接 DTI和静息状态功能MRI(R-fMRI)。共招募144名MCI受试者, 在俄勒冈州的波特兰和密歇根州的底特律进行随机化,与车轮上的膳食和地区机构合作 在这两个地点的老龄化(AAA),创造了一个大的抽样框架,那些低收入和种族 少数群体一半的参与者将被随机选择并被邀请参加大脑成像研究。 通过通信技术增加日常社会联系可以提供一个具有成本效益的家庭- 基于预防,可以减缓认知能力下降,延迟AD的发作,从而减少整体 痴呆症的社会负担。在大多数发达国家,最年长的老年人是人口中增长最快的部分。 在这些国家中,老年痴呆症和社会隔离的风险最高(不利健康的风险因素 成果)。这一人群迫切需要方便用户的可持续预防方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIROKO Hayama DODGE其他文献

HIROKO Hayama DODGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIROKO Hayama DODGE', 18)}}的其他基金

Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
使用机器学习从语言和行为标记识别轻度认知障碍
  • 批准号:
    10709094
  • 财政年份:
    2021
  • 资助金额:
    $ 40.23万
  • 项目类别:
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
使用机器学习从语言和行为标记识别轻度认知障碍
  • 批准号:
    10212669
  • 财政年份:
    2021
  • 资助金额:
    $ 40.23万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10369036
  • 财政年份:
    2020
  • 资助金额:
    $ 40.23万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10203772
  • 财政年份:
    2020
  • 资助金额:
    $ 40.23万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10641031
  • 财政年份:
    2020
  • 资助金额:
    $ 40.23万
  • 项目类别:
Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I
基于网络的社交互动可延缓 MCI 老年人认知能力下降:第一阶段
  • 批准号:
    9311584
  • 财政年份:
    2017
  • 资助金额:
    $ 40.23万
  • 项目类别:
Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I
基于网络的社交互动可延缓 MCI 老年人认知能力下降:第一阶段
  • 批准号:
    9898209
  • 财政年份:
    2017
  • 资助金额:
    $ 40.23万
  • 项目类别:
Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I Administrative Supplement
基于网络的社交互动可延缓 MCI 老年人认知能力下降:第一阶段行政补充
  • 批准号:
    10363310
  • 财政年份:
    2017
  • 资助金额:
    $ 40.23万
  • 项目类别:
Conversational Engagement as a Means to Delay Onset AD: Phase II Administrative Supplement
对话参与作为延迟 AD 发作的一种手段:第二阶段行政补充
  • 批准号:
    10058784
  • 财政年份:
    2016
  • 资助金额:
    $ 40.23万
  • 项目类别:
Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I
基于网络的社交互动可延缓 MCI 老年人认知能力下降:第一阶段
  • 批准号:
    9348726
  • 财政年份:
    2016
  • 资助金额:
    $ 40.23万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 40.23万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 40.23万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 40.23万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 40.23万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 40.23万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 40.23万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 40.23万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 40.23万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 40.23万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 40.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了